Saketha Drugs And Intermediates Limited

Manufactures and trades pharmaceuticals, chemicals, and herbal medicines since 1995.

1995 | K.V.Rangareddy, Telangana (India) | Converted to LLP
Last Updated:

Saketha Drugs And Intermediates Profile

Key Indicators

  • Authorised Capital ₹ 1,840.00 Cr
  • Paid Up Capital ₹ 1,828.95 Cr
  • Company Age 29 Year, 11 Months
  • Last Filing with ROC 31 Mar 2016
  • Revenue Growth %
  • Profit Growth 63.73%
  • Ebitda 63.73%
  • Net Worth -0.97%
  • Total Assets 1.98%

About Saketha Drugs And Intermediates

Saketha Drugs And Intermediates Limited (SDAIL) is Converted To Llp company established on 08 Jun 1995 with its office registered at K.V.Rangareddy, Telangana, India and has been running since 29 Year, 11 Months with a paid up capital of 1,828.95 Cr. According to MCA records, 0 Directors are linked to this company as of 14 May 2024.

Company Details

  • Location

    K.V.Rangareddy, Telangana, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U24239TG1995PLC020625

  • Company No.

    020625

  • Company Classification

    Public Limited Indian Non-Government Company

  • Incorporation Date

    08 Jun 1995

  • Date of AGM

    26 May 2016

  • Date of Balance Sheet

    31 Mar 2016

  • Listing Status

    Unlisted

  • ROC Code

    Roc-Hyderabad

Industry

Pharma
Company report

Saketha Drugs And Intermediates Limited

Explore comprehensive data for Saketha Drugs And Intermediates Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Saketha Drugs And Intermediates?

Board Members

People

No Directors or KMP associated with company. Upon reviewing the records, we can confirm that there are no Directors or Key Management Personnel (KMP) associated with this company at present.

Financial Performance of Saketha Drugs And Intermediates.

Saketha Drugs And Intermediates Limited, for the financial year ended 2016, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 63.73% increase in profit. The company's net worth dipped by a decrease of 0.97%.

Saketha Drugs And Intermediates revenue growth over time
Saketha Drugs And Intermediates profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
Revenue from Operations
Total Assets
1.98%
Profit or Loss
63.73%
Net Worth
-0.97%
EBITDA
63.73%

What is the Ownership and Shareholding Structure of Saketha Drugs And Intermediates?

In 2016, Saketha Drugs And Intermediates had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Saketha Drugs And Intermediates?

Unlock and access historical data on people associated with Saketha Drugs And Intermediates, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Saketha Drugs And Intermediates Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Saketha Drugs And Intermediates, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Saketha Drugs And Intermediates's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Saketha Drugs And Intermediates

Recent activity within the organization

  • Annual General Meeting

    Saketha Drugs And Intermediates Limited last Annual general meeting of members was held on 26 May 2016 as per latest MCA records.

  • Balance Sheet

    Saketha Drugs And Intermediates Limited has filed its annual Financial statements for the year ended 31 Mar 2016 with RoC-Hyderabad.

  • Company Incorporation

    Saketha Drugs And Intermediates Limited was registered on 08 Jun 1995 with RoC-Hyderabad & aged 29 years 11 months as per MCA records.

Frequently asked questions

  • What is the Incorporation or founding date of Saketha Drugs And Intermediates Limited?

    Saketha Drugs And Intermediates Limited was incorporated on 08 Jun 1995.

  • What is authorized share capital and paid-up capital of Saketha Drugs And Intermediates Limited?

    The authorized share capital of Saketha Drugs And Intermediates Limited is ₹ 1,840.00 Cr and paid-up capital is ₹ 1,828.95 Cr.

  • What is the registered address of Saketha Drugs And Intermediates Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Saketha Drugs And Intermediates Limited is H.No.8-3-166/7/1 Third Floor, Hetero House Erragadda, Hyderabad, Telangana, India, 500018.

  • What is the corporate identification number (CIN) and company number of Saketha Drugs And Intermediates Limited?

    The corporate identification number (CIN) of Saketha Drugs And Intermediates Limited is U24239TG1995PLC020625 and the company number is 020625 as per Ministry of Corporate Affairs (MCA).

  • What change has been observed in the net worth of Saketha Drugs And Intermediates Limited, and by what percentage?

    The financial reports for the fiscal year 2016 indicates that The net worth of Saketha Drugs And Intermediates Limited has experienced an downturn of -0.97%.

  • When was the last Balance Sheet of Saketha Drugs And Intermediates Limited filed with the ROC?

    The most recent Balance Sheet for Saketha Drugs And Intermediates Limited was filed with the ROC on 31 Mar 2016.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial

People also Viewed

Similar Companies Based on Drug Formulation & Development